Quantum BioPharma Ltd. (QNTM)
2.81
-0.01
(-0.35%)
USD |
NASDAQ |
Oct 13, 10:39
Quantum BioPharma Enterprise Value : 10.73M for Oct. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 12, 2026 | 10.73M |
| October 09, 2026 | 11.64M |
| October 08, 2026 | 12.93M |
| October 07, 2026 | 13.19M |
| October 06, 2026 | 12.78M |
| October 05, 2026 | 14.14M |
| October 02, 2026 | 15.43M |
| October 01, 2026 | 15.31M |
| September 30, 2026 | 16.64M |
| September 29, 2026 | 18.31M |
| September 28, 2026 | 19.37M |
| September 25, 2026 | 18.53M |
| September 24, 2026 | 19.67M |
| September 23, 2026 | 18.76M |
| September 22, 2026 | 17.40M |
| September 21, 2026 | 16.72M |
| September 18, 2026 | 17.10M |
| September 17, 2026 | 17.55M |
| September 16, 2026 | 17.02M |
| September 15, 2026 | 15.58M |
| September 14, 2026 | 15.58M |
| September 11, 2026 | 13.61M |
| September 10, 2026 | 14.29M |
| September 09, 2026 | 16.49M |
| September 08, 2026 | 14.29M |
| Date | Value |
|---|---|
| September 04, 2026 | 13.91M |
| September 03, 2026 | 11.72M |
| September 02, 2026 | 12.70M |
| September 01, 2026 | 12.40M |
| August 31, 2026 | 13.38M |
| August 28, 2026 | 12.66M |
| August 27, 2026 | 13.08M |
| August 26, 2026 | 12.62M |
| August 25, 2026 | 14.22M |
| August 24, 2026 | 13.91M |
| August 21, 2026 | 15.43M |
| August 20, 2026 | 15.43M |
| August 19, 2026 | 16.03M |
| August 18, 2026 | 14.67M |
| August 17, 2026 | 17.25M |
| August 14, 2026 | 18.16M |
| August 13, 2026 | 13.84M |
| August 12, 2026 | 15.73M |
| August 11, 2026 | 16.26M |
| August 10, 2026 | 15.58M |
| August 07, 2026 | 15.50M |
| August 06, 2026 | 13.84M |
| August 05, 2026 | 11.34M |
| August 04, 2026 | 11.11M |
| August 03, 2026 | 12.47M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Numinus Wellness, Inc. | 6.632M |
| Cocrystal Pharma, Inc. | 13.71M |
| Edesa Biotech, Inc. | 26.40M |
| CNBX Pharmaceuticals, Inc. | 1.453M |
| Invion Ltd. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.093M |
| Total Expenses (Quarterly) | 3.253M |
| EPS Diluted (Quarterly) | -0.4891 |
| Earnings Yield | -202.4% |
| Normalized Earnings Yield | -127.64 |